Development of a High-Throughput Homogeneous AlphaLISA Drug Screening Assay for the Detection of SARS-CoV-2 Nucleocapsid

ACS Pharmacology & Translational Science
K. GorshkovW. Zheng

Abstract

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is in urgent need of therapeutic options. High-throughput screening (HTS) offers an opportunity to rapidly identify such compounds. In this work, we have developed a homogeneous cell-based HTS system using AlphaLISA detection technology for the SARS-CoV-2 nucleocapsid protein (NP). Our assay measures both recombinant and endogenous NP from viral lysates and tissue culture supernatants (TCS) in a sandwich-based format using two monoclonal antibodies against the NP analyte. Viral NP was detected and quantified in both tissue culture supernatants and cell lysates, with large differences observed between 24 and 48 h of infection. We simulated viral infection by spiking recombinant NP into 384-well plates with live Vero-E6 cells and were able to detect the NP with high sensitivity and a large dynamic range. Antiviral agents that inhibit either viral cell entry or replication decrease the AlphaLISA NP signal. Thus, this assay can be used for high-throughput screening of small molecules and biologics in the fight against the COVID-19 pandemic.

References

Jul 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·James IngleseChristopher P Austin
Apr 23, 2009·Assay and Drug Development Technologies·Martina Bielefeld-Sevigny
Feb 23, 2020·The Lancet Infectious Diseases·Ensheng DongLauren Gardner
Apr 1, 2020·The New England Journal of Medicine·Nicole LurieJane Halton
Apr 7, 2020·Trends in Immunology·Shibo JiangLanying Du
Apr 8, 2020·Proceedings of the National Academy of Sciences of the United States of America·Kai DuanXiaoming Yang
Apr 8, 2020·Immunity·Fatima Amanat, Florian Krammer
Jul 9, 2020·BioRxiv : the Preprint Server for Biology·Leonid YurkovetskiyJeremy Luban

❮ Previous
Next ❯

Citations

Jul 19, 2021·Current Opinion in Chemical Biology·Fabio UrbinaSean Ekins

❮ Previous
Next ❯

Datasets Mentioned

BETA
MN985325.1

Methods Mentioned

BETA
ELISA
AlphaLISA
Assay
Infection

Key Resources (RRID) Mentioned

CVCL_0574

Software Mentioned

Biorender
Graphpad Prism
AlphaLISA

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.